Cargando...
The pharmacogenomics of drug resistance to protein kinase inhibitors
Dysregulation of growth factor cell signaling is a major driver of most human cancers. This has led to development of numerous drugs targeting protein kinases, with demonstrated efficacy in the treatment of a wide spectrum of cancers. Despite their high initial response rates and survival benefits,...
Guardado en:
| Publicado en: | Drug Resist Updat |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5022787/ https://ncbi.nlm.nih.gov/pubmed/27620953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drup.2016.06.008 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|